Depending on the individual goals a beginner will find comfortable Turinabol doses in the range of 15 – 30mg per day, although this is considered a low dose range where gains will not be exceptionally dramatic by any means. Such a Turinabol dose would provide noticeable but steady lean gains and almost nothing in the way of unwanted side effects except for those most sensitive. Intermediate users would find greater progress in the way of strength and mass gains upwards of 30 – 50mg per day with still very low incidences or chances of unwanted side effects. Advanced Turinabol doses land in the range of 50 – 80mg per day sometimes higher which would of course provide more dramatic strength and mass gains but at the expense of increased androgenic side effects at such an increased Turinabol dose. In general most users find satisfactory results in the middle of the total previously mentioned doses, which would be around 50mg per day. Doses lower than 40mg per day tend to be utilized merely for the preservation of lean mass during fat loss and cutting phases.
Dosage of Proviron 25 Mg:
In general, the recommended dosage of is 25-100 mg per day. The duration of this use should last for a maximum of 12 weeks.
The half-life of Proviron 25 Mg is close to 12-24 hours, therefore it is necessary to divide the dosage into 2-3 times a day. The oral form of this drug taken can stay in the body for a long time and is rapidly absorbed in the blood stream. To get the full effect, the drug is often combined with Tamoxifen or Arimidex and usually taken during the wash out phase.
In March 2006, Merck KGaA announced a € bid for Schering AG , which had been founded in 1851 and by 2006 had annual gross revenue of around €5 billion  and employed about 26,000 people in 140 subsidiaries worldwide.  Bayer responded with a white knight bid and in July acquired the majority of shares of Schering for €,  and in 2007, Bayer took over Schering AG and formed Bayer Schering Pharma. The acquisition of Schering was the largest take-over in Bayer's history,  : 49–52  and as of 2015 this was one of the ten biggest pharma mergers of all time.